Trials / Completed
CompletedNCT03984721
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is to establish that a new technique of amyloidosis typing by Proteomics (based on nanoLC-MS/MS mass spectrometry) allows typing in \> 90% of observations in patients whose Amyloidosis is reported to have failed typing (impossible typing, uncertain or inconsistent) with the traditional anatomopathological approach, and this in a cohort of 40 patients identified consecutively in the Department of pathological anatomy and cytology of the University Hospital of Toulouse and included prospectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Amyloidosis typing using mass spectrometry-based proteomics | Amyloidosis typing using nanoLC-MS/MS method |
Timeline
- Start date
- 2019-07-25
- Primary completion
- 2021-09-08
- Completion
- 2021-09-08
- First posted
- 2019-06-13
- Last updated
- 2023-07-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03984721. Inclusion in this directory is not an endorsement.